D3 Technologies Ltd is a pioneer in the field of molecular detection systems. The company uses the highly selective and sensitive techniques of surface enhanced Raman scattering (SERS) and surface enhanced resonance Raman scattering (SERRS) to produce products with superior detection capability.
One of the company's delivery systems in the most advanced stages of clinical development is a novel drug delivery system for Paclitaxel. Because of the better safety and pharmacokinetic profile, the polymeric nanoparticle delivery system is seen as a potential super generic.
Degussa is a leading specialty chemicals company. They see nanotechnology as an opportunity to develop new products and efficient solutions that are vital to improve environmental protection, health and product quality.
Dekati's core competence and expertise is in the design and manufacture of innovative fine particle measuring and sampling devices, including an Electrical Low Pressure Impactor (ELPI) for combustion aerosol measurements, enabling real time particle size distribution and concentration measurement from 7 nm.
Del Mar offers integration of femtosecond laser systems for research of ultrafast dynamics in nanophotonics, as well as multiphoton imaging, scanning probe microscopy, micromachining, ultrafast fluorescent kinetic and transient pump-probe absorption spectroscopy systems.
DELMIC products are focused on high performance, user friendly, integrated, solutions. The company has two product lines: The SECOM platform for correlative fluorescence and electron microscopy, primarily used in the life sciences. The SPARC system for high-performance cathodoluminescence detection, primarily used in nanophotonics.
The Delong group of companies operates in the high tech, engineering design, manufacturing and sales sectors and span two continents with operations in Europe and North America. The company manufactures the desktop LVEM5 electron microscope.
Delpor develops the next generation Drug Delivery Systems that improve the clinical and commercial value of drugs and biopharmaceuticals. The company also has developed a microfabricated nanopore device for the sustained release of therapeutic agents.
The company's NLP technology produces a generation of particles which retains the strength of the Dermazone Solutions' (SDMC) technologies, but includes the ability to produce particles of 60 nanometers to 150 nanometers which are optically clear. The use of this generation of lipid-based particle delivery system provides the ability to control the size of the final particle by controlling the number of NLPs used to assemble the finished particle. This system maintains very high loading capacity of passenger molecules and uses only safe, all natural ingredients to form both the NLPs and the final delivery system.
The company's coating process works at nanoscale levels, approximately 30 nanometers. The change of the molecular composition of the silica-based surface created by bonding nanoparticles enables the full efficiency of the coating process at an atomic scale.